InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,296.92
(
0.00%
)
US TECH 100
18,078.80
(
0.00%
)
Dow Jones
39,912.31
(
0.11%
)
Brent Oil
83.20
(
-0.01%
)
Bitcoin
66,054.34
(
1.25%
)
Post# of 402865
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

djs7

Send PM Follow Ignore
Followers 7
Posts 578
Boards Moderated 0
Alias Born 08/29/2014

djs7

Re: scottsmith post# 194572

Thursday, 08/24/2017 9:59:56 PM

Thursday, August 24, 2017 9:59:56 PM

Post# of 402865
Can you or anyone else provide example(s) within the recent past 3-5 years where an Interim Analysis for a psoriasis trial was released by any Biotech/Big Pharma company at the 50%-70% completion mark because results were blowing the lid off the roof??
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM

Start posting your company's news
Only $200 per official company press release!